-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on NewAmsterdam Pharma Co NV (NAMS)
-
-
-
-
-
-
-
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
-
-
-
-
-
-
-
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter 2023 Financial Highlights
-
-
-
1,233,845 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


